ESOP/ESOS/ESPS

September 1, 2026 BSE Limited National Stock Exchange of India Limited P J Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543904 Symbol: MANKIND Dear Sir/Madam, Sub: Allotment of 49,112 Equity Shares under Mankind Employee Stock Option Plan 2022 (“ESOP Plan”) Ref: Regulation 10(c) of the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 (“SBEB Regulations”) This is to inform you that the Nomination and Remuneration Committee of the Board of Directors of Mankind Pharma Limited (“Company”) vide circular resolution passed today i.e. September 1, 2026, has allotted 49,112 equity shares of face value of ₹1/- each of the Company to the eligible employees who has exercised their options pursuant to the ESOP Plan. These shares shall rank pari-passu with the existing equity shares of the Company. Consequent to the aforesaid allotment, the paid-up share capital of the Company has increased from 41,29,95,978 Equity Shares to 41,30,45,090 Equity Shares having face value of ₹1/- each. The details as required under Regulation 10(c) read with Part-E of Schedule I of the SBEB Regulations, are enclosed herewith as “Annexure - I”. The same is being uploaded on website of the Company at www.mankindpharma.com. You are requested to kindly take the above on record. Yours faithfully, For Mankind Pharma Limited Hitesh Kumar Jain Company Secretary & Compliance Officer Encl.: A/a Annexure -I Disclosure as per Regulation 10(c) read with Part-E of Schedule I of the SBEB Regulations: S. No. Particulars Details 1 Company name and address of Registered Office Mankind Pharma Limited 208, Okhla Industrial Estate, Phase-III, New Delhi- 110020 2 Name of the recognized Stock Exchanges on which National Stock Exchange of India Limited the company's shares are listed (“NSE”) and BSE Limited (“BSE”) 3 Filing date of the statement referred in regulation September 27, 2023 10(b) SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 with Stock Exchange 4 Filing Number, if any NSE - 37696 BSE – 185760 5 Title of the Scheme pursuant to which shares are Mankind Employee Stock Option Plan 2022 issued, if any 6 Kind of security to be listed Equity Shares 7 Par value of the shares ₹1/- per equity share 8 Date of issue of shares September 1, 2026 9 Number of shares issued 49,112 10 Share Certificate No., if applicable Not Applicable 11 Distinctive number of the share, if applicable 41,29,95,979 to 41,30,45,090 (Both Inclusive) 12 ISIN Number of the shares if issued in Demat INE634S01028 13 Exercise price per share A. ₹860.00/- per equity share 14 Premium per share A. ₹859.00/- per equity share 15 Total Issued shares after this issue 41,30,45,090 16 Total Issued share capital after this issue ₹ 41,30,45,090/- 17 Details of any lock-in on the shares Not Applicable 18 Date of expiry of lock-in Not Applicable 19 Whether shares are identical in all respects to All equity shares allotted pursuant to exercise existing Shares? If not, when will they become of options shall rank pari-passu with the identical? existing equity shares of the Company. 20 Details of listing fees, if payable Not Applicable For Mankind Pharma Limited Hitesh Kumar Jain Company Secretary & Compliance Officer Date: September 1, 2026 Place: New Delhi